Research map: Direct Oral Anticoagulants for Atrial Fibrillation in Patients Receiving Hemodialysis: A Review and Discussion of Evidence

Back to the article

Papers in this map

  1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation · Stuart J. Connolly · 2009 · 11278 citations · Cited by this paper
  2. Exosome Therapy: A Novel Investigational Approach in Acute Myocardial Infarction · 2026 · Related
  3. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation · Manesh R. Patel · 2011 · 9485 citations · Cited by this paper
  4. Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection · 2026 · Related
  5. Apixaban versus Warfarin in Patients with Atrial Fibrillation · Christopher Bull Granger · 2011 · 9000 citations · Cited by this paper
  6. Women in Heart Failure With Preserved Ejection Fraction Clinical Trials: Bridging the Gap Between Trial Enrollment and Real-World Disease Burden · 2026 · Related
  7. Edoxaban versus Warfarin in Patients with Atrial Fibrillation · Robert Patrick Giugliano · 2013 · 5198 citations · Cited by this paper
  8. Anesthetic-Electrophysiologic Interactions: How Sedatives Shape Cardiac Conduction and Arrhythmia Risk · 2026 · Related
  9. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) · Isabelle C. Van Gelder · 2024 · 2934 citations · Cited by this paper
  10. Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management · 2026 · Related
  11. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · José A. Joglar · 2023 · 2728 citations · Cited by this paper
  12. Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation · 2026 · Related
  13. Antithrombotic Therapy for Atrial Fibrillation · Gregory Y.H. Lip · 2018 · 952 citations · Cited by this paper
  14. Impella Outcomes in Acute Myocardial Infarction Versus Non–Acute Myocardial Infarction Cardiogenic Shock: A United States Nationwide Propensity-Matched Analysis (2016–2022) · 2026 · Related
  15. Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation · Yi Wan · 2008 · 513 citations · Cited by this paper
  16. Chocolate and Cardiovascular Disease · 2026 · Related
  17. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor · Dagmar Kubitza · 2010 · 434 citations · Cited by this paper
  18. Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population · 2026 · Related
  19. Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis · Xiaoli Wang · 2015 · 288 citations · Cited by this paper
  20. Ranolazine: An Antiarrhythmic and Cardioprotective Agent · 2026 · Related
  21. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial · Sean D. Pokorney · 2022 · 235 citations · Cited by this paper
  22. Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients · Thomas A. Mavrakanas · 2017 · 227 citations · Cited by this paper
  23. Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial · An S. De Vriese · 2021 · 193 citations · Cited by this paper
  24. A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study · Holger Reinecke · 2022 · 188 citations · Cited by this paper
  25. Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists · Martijn L. L. Chatrou · 2012 · 179 citations · Cited by this paper
  26. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study · An S. De Vriese · 2019 · 178 citations · Cited by this paper
  27. Warfarin Dosing in Patients With Impaired Kidney Function · Nita A. Limdi · 2010 · 176 citations · Cited by this paper
  28. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study · Leif Friberg · 2014 · 163 citations · Cited by this paper
  29. Chronic Kidney Disease and Cerebrovascular Disease · Dearbhla Kelly · 2021 · 155 citations · Cited by this paper
  30. Dose-Finding Study of Rivaroxaban in Hemodialysis Patients · An S. De Vriese · 2015 · 148 citations · Cited by this paper
  31. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease · Mandeep Singh Randhawa · 2020 · 144 citations · Cited by this paper
  32. Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis · Clapton S. Dias · 2016 · 133 citations · Cited by this paper
  33. Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation · Simonetta Genovesi · 2014 · 108 citations · Cited by this paper
  34. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease · Felix Yang · 2016 · 107 citations · Cited by this paper
  35. Cytochrome P4502C9 activity in end‐stage renal disease · Albert W. Dreisbach · 2003 · 105 citations · Cited by this paper
  36. EFFECT OF RENAL FAILURE ON DRUG METABOLISM BY THE LIVER · A. ELSTON · 1993 · 101 citations · Cited by this paper
  37. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation · Thomas A. Mavrakanas · 2020 · 101 citations · Cited by this paper
  38. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis · Hans Van Der Meersch · 2016 · 96 citations · Cited by this paper
  39. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease · Nishank Jain · 2018 · 90 citations · Cited by this paper

Source: OpenAlex (CC0)